Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma.

Autor: Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Johnson PC; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Yang D; Duke University School of Medicine, Durham, NC, USA., Holmbeck K; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Choe J; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Nabily A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Lark P; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Dhawale T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Amonoo HL; Harvard Medical School, Boston, MA, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA., El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 441-449.

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy.

Autor: Barata A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: abarata@mgh.harvard.edu., Dhawale T; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Newcomb RA; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Amonoo HL; Harvard Medical School, Boston, Massachusetts; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Nelson AM; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Yang D; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Karpinski K; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Holmbeck K; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Farnam E; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Frigault M; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Johnson PC; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., El-Jawahri A; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Apr; Vol. 30 (4), pp. 452.e1-452.e11. Date of Electronic Publication: 2024 Jan 17.

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients.

Autor: Johnson PC; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Dhawale T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Barata A; Harvard Medical School, Boston, MA.; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Karpinski K; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Lavoie MW; UMass Chan Medical School, Worchester, MA., Vaughn D; University of Tennessee Health Science Center College of Medicine, Memphis, TN., Hennessey K; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Schneider D; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Amonoo HL; Harvard Medical School, Boston, MA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Volandes A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Feb 27; Vol. 22 (2). Date of Electronic Publication: 2024 Feb 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM.

Autor: Epstein MM; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA., Dutcher SK; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Maro JC; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., Saphirak C; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA., DeLuccia S; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA., Dhawale T; Division of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Harchandani S; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA., Delude C; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA., Hou L; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., Gertz A; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., DiNunzio N; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., McMahill-Walraven CN; Aetna, a CVS Health company, Hartford, Connecticut, USA., Selvan MS; Humana Healthcare Research, Inc. (HHR), Sugar Land, Texas, USA., Vigeant J; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., Cole DV; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA., Leishear K; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Gurwitz JH; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA., Andrade S; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA., Cocoros NM; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Jul; Vol. 30 (7), pp. 910-917. Date of Electronic Publication: 2021 May 05.